Presented at: AACR 2020
Relevant for
FixVUE, InSituPlex
Presented at: AACR 2020
Relevant for
Collaboration, FixVUE, InSituPlex
Presented at: AACR 2020
Relevant for
Collaboration, InSituPlex
Relevant for
Collaboration, FixVUE, InSituPlex
Description Profiling multiple cell types in tissue samples requires more markers than can be supported by conventional approaches to immunohistochemistry. InSituPlex® multipleximmunofluorescence (mIF) technology enables biomarker multiplexing int issue samples with an automated workflow to support discovery of immunecell signatures in the tumor immunemicroenvironment (TiME).Here we have designed and tested an 8- plex immuno phenotyping panel using the InSituPlex® approach to detect and classify T cells, macrophages, and tumor cell in non- small cell lung cancer (NSCLC) and colorectal cancer (CRC) FFPE tissue.
Anne Hellebust, Kyla Teplitz, Katir K Patel, Karan Sharma, Amanda Bares, Mael Manesse, Mark Burton, Bonnie Phillips, Sean Downing and Kate Lillard
Presented at: AACR 2020
Relevant for
FixVUE, InSituPlex
Douglas Wood, Heike Boisvert, Sean R. Downing and Maël Manesse
Presented at: AACR 2020
Relevant for
Collaboration, FixVUE, InSituPlex
Douglas Wood, Heike Boisvert, Sean R. Downing and Maël Manesse
Relevant for
Collaboration, FixVUE, InSituPlex
Description Profiling multiple cell types in tissue samples requires more markers than can be supported by conventional approaches to immunohistochemistry. InSituPlex® multipleximmunofluorescence (mIF) technology enables biomarker multiplexing int issue samples with an automated workflow to support discovery of immunecell signatures in the tumor immunemicroenvironment (TiME).Here we have designed and tested an 8- plex immuno phenotyping panel using the InSituPlex® approach to detect and classify T cells, macrophages, and tumor cell in non- small cell lung cancer (NSCLC) and colorectal cancer (CRC) FFPE tissue.
